Kantelhardt et al. [54] demonstrated that glioma cells expressing highly upregulated EGFR, in contrast to normal brain tissue lacking this receptor, were selectively labeled by quantum dots specifically targeted to the EGFR. This evidence concerns the gene EGFR and central nervous system cancer.